MATLIN DAVID J (Chief Financial Officer) reported 1 transaction at TRISALUS LIFE SCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/1/2026ACC: 0001628280-26-022792
DirectorOfficer10% Owner· Chief Financial Officer
Since Dec 2020
+230K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
330K acquired · 100K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+330K
Price / share
—
Trade value
—
% of position
35.0%
7/31/2025
941.94K→1.27M
Total
Net shares
+330K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2025 | C · Conversion | +330K | — | — | 35.0% | 941.94K | 1.27M |
| Total | +330K | $0.00 | ||||||
Derivative Transactions1
Series A Preferred Stock
Direct
Converts to
Common Stock
330K shares
Shares
−100K
Strike price
4
Held after
0.00
Exercisable
—
7/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock330K shares | 7/31/2025 | C · Conversion | −100K | 4 | — | 0.00 |